Amundi
ABBV icon

Amundi’s AbbVie ABBV Stock Holding History

Amundi’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33B Buy
10,698,095
+247,689
+2% +$54.9M 0.63% 19
2025
Q4 		$2.39B Sell
10,450,406
-57,911
-0.6% -$13.2M 0.65% 17
2025
Q3 		$2.42B Buy
10,508,317
+1,414,621
+16% +$288M 0.78% 17
2025
Q2 		$1.73B Buy
9,093,696
+2,435,372
+37% +$453M 0.6% 22
2025
Q1 		$1.34B Sell
6,658,324
-1,688,972
-20% -$328M 0.49% 37
2024
Q4 		$1.49B Buy
8,347,296
+717,403
+9% +$132M 0.52% 30
2024
Q3 		$1.47B Buy
7,629,893
+520,371
+7% +$97.1M 0.54% 34
2024
Q2 		$1.16B Buy
7,109,522
+807,799
+13% +$134M 0.45% 46
2024
Q1 		$1.04B Sell
6,301,723
-1,680,202
-21% -$290M 0.45% 38
2023
Q4 		$1.3B Sell
7,981,925
-235,414
-3% -$34.3M 0.58% 25
2023
Q3 		$1.22B Sell
8,217,339
-838,371
-9% -$123M 0.6% 24
2023
Q2 		$1.22B Buy
9,055,710
+403,503
+5% +$59.2M 0.62% 24
2023
Q1 		$1.39B Buy
8,652,207
+2,494,894
+41% +$381M 0.75% 20
2022
Q4 		$969M Buy
6,157,313
+997,983
+19% +$153M 0.53% 28
2022
Q3 		$739M Sell
5,159,330
-346,952
-6% -$49.8M 0.44% 39
2022
Q2 		$828M Buy
5,506,282
+783,076
+17% +$120M 0.66% 25
2022
Q1 		$818M Sell
4,723,206
-958,881
-17% -$139M 0.55% 31
2021
Q4 		$760M Sell
5,682,087
-134,837
-2% -$15.9M 0.48% 41
2021
Q3 		$627M Buy
5,816,924
+1,236,167
+27% +$141M 0.44% 49
2021
Q2 		$516M Buy
+4,580,757
New +$516M 0.36% 57

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amundi's ABBV Position: Q1 2026 in Review

Amundi increased its AbbVie (ABBV) stake by 2.4% in Q1 2026, buying an estimated $54.9M and bringing the position to 10,698,095 shares worth $2.33B. The position accounts for 0.63% of the portfolio, ranked #19.

Amundi first reported a position in ABBV in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.42B in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Amundi held 10,698,095 shares of AbbVie worth $2.33B as of Q1 2026.
  • Amundi bought 247,689 AbbVie shares in Q1 2026, an estimated $54.9M.
  • AbbVie made up 0.63% of Amundi's portfolio in Q1 2026, its #19 holding.
  • Amundi first reported a position in AbbVie in Q2 2021 and has held it in 20 quarters since.
  • Amundi's AbbVie position peaked at $2.42B in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.